Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions
Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions is a paper indexed in PICO Portal from OpenAlex.
How many citations does Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions have?
Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions has 286 citations in the OpenAlex counts PICO Portal stores.
When was Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions published?
Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions has 2018 year in the PICO Portal index.
What is the open-access status of Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions?
Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions has bronze oa status in the PICO Portal index.
What is the DOI of Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions?
The DOI for Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions is on the source record.
What is the PMID of Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions?
The PMID for Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions is on the source record.
What is the OpenAlex record for Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions?
The OpenAlex for Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions is on the source record.